Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.97
-0.53-3.24%
Last update: Oct 7, 4:44 PM
$15.90
-0.60-3.67%
NeoGenomics Inc (NEO) Stock Price, Quote, News & History
NEONASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NeoGenomics (NASDAQ:NEO) through any online brokerage.
Other companies in NeoGenomics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
NeoGenomics has a consensus price target of $17.29.
The stock price for NeoGenomics (NASDAQ: NEO) is $15.9 last updated October 7, 2026 at 4:44 PM EDT.
There are no upcoming dividends for NeoGenomics.
NeoGenomics does not have any upcoming earnings scheduled.
There is no upcoming split for NeoGenomics.
NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
